• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • China suspends bone graft material from HansBiomedCorp

China suspends bone graft material from HansBiomedCorp

China-suspends-bone-graft-material
Tuesday, 20 June 2023 / Published in Medical Device, News, NMPA Registration in China

China suspends bone graft material from HansBiomedCorp

China suspends bone graft material from HansBiomedCorp (South Korea) following a remote off-site inspection by the National Medical Products Administration (NMPA).

The medical device under inspection was an allogeneic bone repair material:

  • English name: ExFuseBoneGraft
  • registration number: 20193130564
  • production address: 64, Yuseong-daero1628beon-gil, Yuseong-gu, Daejeon, Korea

The inspection found that the production process of the product had problems such as failure to take effective control measures for key raw materials and insufficient environmental monitoring in the clean area.

Therefore, in order to ensure the safety of devices used by the public, and in accordance with the relevant provisions of the “Regulations on the Supervision and Administration of Medical Devices” and the “Measures for the Supervision and Administration of Medical Device Production”, the NMPA has decided to suspend the import, operation and use of allogeneic bone repair materials from HansBiomedCorp in South Korea from now on.

Medical device companies are required to adhere to the Good Manufacturing Practice for Medical Devices – more information can be found here.

As this product is an implantable medical device, it must also comply with the “Medical Device Production Quality Management Code Appendix for Implantable Medical Devices”.

Consequences of non-compliance:

According to Article 86 of the Regulations for the Supervision and Administration of Medical Devices, the department in charge of drug supervision and administration shall order rectification and confiscate the medical devices produced and operated illegally:

  • if the amount of the medical devices produced and operated illegally is less than 10,000 yuan, a fine of more than 20,000 yuan and less than 50,000 yuan shall be imposed;
  • if the amount of the goods is more than 10,000 yuan, a fine of more than 5 times the value of the goods and less than 20 times the value of the goods shall be imposed.

Further information

Read the original article on China suspends bone graft material from HansBiomedCorp.

Ensure your medical device QMS and GMP meet China requirements – contact Cisema to organize a pre-audit. Discover our services for medical device registration, renewals and NMPA Legal Agent.

GET IN TOUCH

🌐 Send us your enquiry
📚 Request our whitepapers
📣 Sign up for our newsletter

What you can read next

China Implements Trial Version of Real-World Data Guidelines
Clinical Trials GMP management
Clinical Trials GMP Management Specification for Drugs – Appendix (Draft) Issued
Guidelines for the Information Submission of Cosmetics Registration and Filing (Trial Version)

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • laser therapy devices

    Clinical evaluation of laser therapy devices – New guidelines issued

    Clinical evaluation of laser therapy devices ha...
  • dental implant system

    Clinical evaluation of dental implant systems in China – New guidelines issued

    Clinical evaluation of dental implant system ha...
  • China Medical Device Webinar

    China Medical Device Webinar with AdvaMed Accel for U.S. exporters

    The China Medical Device Webinar will be featur...
  • webinar_medical-device-market-authorisation

    Cisema presenting at FORUM Institut: Medical device marketing authorisation for advanced – Masterclass China

    Cisema is delighted to hold a Masterclass with ...
  • generative AI services

    China’s generative AI interim measures now in effect

    China’s generative AI interim measures fo...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP